世界の網膜疾患治療薬市場規模・現状・予測（2021年-2027年）

• 英文タイトル：Global Retinal Disease Therapeutics Market Size, Status and Forecast 2021-2027

• レポートコード：QFJ1-4825 • 出版社/出版日：QYResearch / 2021年6月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥585,000 (USD3,900)	▷ お問い合わせ
Multi User	￥877,500 (USD5,850)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

QYResearch社発行の本調査レポートでは、網膜疾患治療薬の世界市場（2016年～2027年）を対象に調査し、市場動向、主要企業の市場シェア、種類別市場規模（黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症）、用途別市場規模（病院薬局、小売薬局、その他）、主要地域別市場規模（北米、アメリカ、欧州、アジア、日本、中国、韓国、インド、東南アジア、中南米、中東、アフリカ等）、企業情報などをまとめております。 ・市場概要 ・網膜疾患治療薬の市場動向 ・企業の競争状況、市場シェア ・網膜疾患治療薬の種類別市場規模と予測2016-2027（黄斑変性症、糖尿病性黄斑浮腫、糖尿病性網膜症、網膜静脈閉塞症） ・網膜疾患治療薬の用途別市場規模と予測2016-2027（病院薬局、小売薬局、その他） ・網膜疾患治療薬の北米市場規模2016-2027（アメリカ、カナダ） ・網膜疾患治療薬の欧州市場規模2016-2027（ドイツ、フランス、イギリス等） ・網膜疾患治療薬のアジア市場規模2016-2027（日本、中国、韓国、インド、東南アジア等） ・網膜疾患治療薬の中南米市場規模2016-2027（メキシコ、ブラジル） ・網膜疾患治療薬の中東・アフリカ市場規模2016-2027（トルコ、サウジアラビア等） ・主要企業情報（Merck、Novartis、Allergan、Roche、Regeneron、Santen） ・結論

Retinal diseases vary widely, but most of them cause visual symptoms. Retinal diseases can affect any part of your retina, a thin layer of tissue on the inside back wall of your eye.

Market Analysis and Insights: Global Retinal Disease Therapeutics Market
The global Retinal Disease Therapeutics market size is projected to reach US$ XX million by 2027, from US$ XX million in 2020, at a CAGR of XX% during 2021-2027.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Retinal Disease Therapeutics market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Retinal Disease Therapeutics market in terms of revenue.
On the whole, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Retinal Disease Therapeutics market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Retinal Disease Therapeutics market.

Global Retinal Disease Therapeutics Scope and Market Size
Retinal Disease Therapeutics market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Retinal Disease Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2016-2027.

Segment by Type
Macular Degeneration
Diabetic Macular Edema
Diabetic Retinopathy
Retinal Vein Occlusion

Segment by Application
Hospital Pharmacy
Retail Pharmacy
Others

By Region
North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA

By Company
Merck
Novartis
Allergan
Roche
Regeneron
Santen

レポート目次

---

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Retinal Disease Therapeutics Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
1.2.2 Macular Degeneration
1.2.3 Diabetic Macular Edema
1.2.4 Diabetic Retinopathy
1.2.5 Retinal Vein Occlusion
1.3 Market by Application
1.3.1 Global Retinal Disease Therapeutics Market Share by Application: 2016 VS 2021 VS 2027
1.3.2 Hospital Pharmacy
1.3.3 Retail Pharmacy
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered

2 Global Growth Trends
2.1 Global Retinal Disease Therapeutics Market Perspective (2016-2027)
2.2 Retinal Disease Therapeutics Growth Trends by Regions
2.2.1 Retinal Disease Therapeutics Market Size by Regions: 2016 VS 2021 VS 2027
2.2.2 Retinal Disease Therapeutics Historic Market Share by Regions (2016-2021)
2.2.3 Retinal Disease Therapeutics Forecasted Market Size by Regions (2022-2027)
2.3 Retinal Disease Therapeutics Industry Dynamic
2.3.1 Retinal Disease Therapeutics Market Trends
2.3.2 Retinal Disease Therapeutics Market Drivers
2.3.3 Retinal Disease Therapeutics Market Challenges
2.3.4 Retinal Disease Therapeutics Market Restraints

3 Competition Landscape by Key Players
3.1 Global Top Retinal Disease Therapeutics Players by Revenue
3.1.1 Global Top Retinal Disease Therapeutics Players by Revenue (2016-2021)
3.1.2 Global Retinal Disease Therapeutics Revenue Market Share by Players (2016-2021)
3.2 Global Retinal Disease Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Players Covered: Ranking by Retinal Disease Therapeutics Revenue
3.4 Global Retinal Disease Therapeutics Market Concentration Ratio
3.4.1 Global Retinal Disease Therapeutics Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Retinal Disease Therapeutics Revenue in 2020
3.5 Retinal Disease Therapeutics Key Players Head office and Area Served
3.6 Key Players Retinal Disease Therapeutics Product Solution and Service
3.7 Date of Enter into Retinal Disease Therapeutics Market
3.8 Mergers & Acquisitions, Expansion Plans

4 Retinal Disease Therapeutics Breakdown Data by Type
4.1 Global Retinal Disease Therapeutics Historic Market Size by Type (2016-2021)
4.2 Global Retinal Disease Therapeutics Forecasted Market Size by Type (2022-2027)

5 Retinal Disease Therapeutics Breakdown Data by Application
5.1 Global Retinal Disease Therapeutics Historic Market Size by Application (2016-2021)
5.2 Global Retinal Disease Therapeutics Forecasted Market Size by Application (2022-2027)

6 North America
6.1 North America Retinal Disease Therapeutics Market Size (2016-2027)
6.2 North America Retinal Disease Therapeutics Market Size by Type
6.2.1 North America Retinal Disease Therapeutics Market Size by Type (2016-2021)
6.2.2 North America Retinal Disease Therapeutics Market Size by Type (2022-2027)
6.2.3 North America Retinal Disease Therapeutics Market Size by Type (2016-2027)
6.3 North America Retinal Disease Therapeutics Market Size by Application
6.3.1 North America Retinal Disease Therapeutics Market Size by Application (2016-2021)
6.3.2 North America Retinal Disease Therapeutics Market Size by Application (2022-2027)
6.3.3 North America Retinal Disease Therapeutics Market Size by Application (2016-2027)
6.4 North America Retinal Disease Therapeutics Market Size by Country
6.4.1 North America Retinal Disease Therapeutics Market Size by Country (2016-2021)
6.4.2 North America Retinal Disease Therapeutics Market Size by Country (2022-2027)
6.4.3 United States
6.4.4 Canada

7 Europe
7.1 Europe Retinal Disease Therapeutics Market Size (2016-2027)
7.2 Europe Retinal Disease Therapeutics Market Size by Type
7.2.1 Europe Retinal Disease Therapeutics Market Size by Type (2016-2021)
7.2.2 Europe Retinal Disease Therapeutics Market Size by Type (2022-2027)
7.2.3 Europe Retinal Disease Therapeutics Market Size by Type (2016-2027)
7.3 Europe Retinal Disease Therapeutics Market Size by Application
7.3.1 Europe Retinal Disease Therapeutics Market Size by Application (2016-2021)
7.3.2 Europe Retinal Disease Therapeutics Market Size by Application (2022-2027)
7.3.3 Europe Retinal Disease Therapeutics Market Size by Application (2016-2027)
7.4 Europe Retinal Disease Therapeutics Market Size by Country
7.4.1 Europe Retinal Disease Therapeutics Market Size by Country (2016-2021)
7.4.2 Europe Retinal Disease Therapeutics Market Size by Country (2022-2027)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic

8 Asia-Pacific
8.1 Asia-Pacific Retinal Disease Therapeutics Market Size (2016-2027)
8.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Type
8.2.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2016-2021)
8.2.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2022-2027)
8.2.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2016-2027)
8.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Application
8.3.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2016-2021)
8.3.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2022-2027)
8.3.3 Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2016-2027)
8.4 Asia-Pacific Retinal Disease Therapeutics Market Size by Region
8.4.1 Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2016-2021)
8.4.2 Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2022-2027)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia

9 Latin America
9.1 Latin America Retinal Disease Therapeutics Market Size (2016-2027)
9.2 Latin America Retinal Disease Therapeutics Market Size by Type
9.2.1 Latin America Retinal Disease Therapeutics Market Size by Type (2016-2021)
9.2.2 Latin America Retinal Disease Therapeutics Market Size by Type (2022-2027)
9.2.3 Latin America Retinal Disease Therapeutics Market Size by Type (2016-2027)
9.3 Latin America Retinal Disease Therapeutics Market Size by Application
9.3.1 Latin America Retinal Disease Therapeutics Market Size by Application (2016-2021)
9.3.2 Latin America Retinal Disease Therapeutics Market Size by Application (2022-2027)
9.3.3 Latin America Retinal Disease Therapeutics Market Size by Application (2016-2027)
9.4 Latin America Retinal Disease Therapeutics Market Size by Country
9.4.1 Latin America Retinal Disease Therapeutics Market Size by Country (2016-2021)
9.4.2 Latin America Retinal Disease Therapeutics Market Size by Country (2022-2027)
9.4.3 Mexico
9.4.4 Brazil

10 Middle East & Africa
10.1 Middle East & Africa Retinal Disease Therapeutics Market Size (2016-2027)
10.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type
10.2.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2016-2021)
10.2.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2022-2027)
10.2.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2016-2027)
10.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Application
10.3.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2016-2021)
10.3.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2022-2027)
10.3.3 Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2016-2027)
10.4 Middle East & Africa Retinal Disease Therapeutics Market Size by Country
10.4.1 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2016-2021)
10.4.2 Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2022-2027)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE

11 Key Players Profiles
11.1 Merck
11.1.1 Merck Company Details
11.1.2 Merck Business Overview
11.1.3 Merck Retinal Disease Therapeutics Introduction
11.1.4 Merck Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.1.5 Merck Recent Development
11.2 Novartis
11.2.1 Novartis Company Details
11.2.2 Novartis Business Overview
11.2.3 Novartis Retinal Disease Therapeutics Introduction
11.2.4 Novartis Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.2.5 Novartis Recent Development
11.3 Allergan
11.3.1 Allergan Company Details
11.3.2 Allergan Business Overview
11.3.3 Allergan Retinal Disease Therapeutics Introduction
11.3.4 Allergan Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.3.5 Allergan Recent Development
11.4 Roche
11.4.1 Roche Company Details
11.4.2 Roche Business Overview
11.4.3 Roche Retinal Disease Therapeutics Introduction
11.4.4 Roche Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.4.5 Roche Recent Development
11.5 Regeneron
11.5.1 Regeneron Company Details
11.5.2 Regeneron Business Overview
11.5.3 Regeneron Retinal Disease Therapeutics Introduction
11.5.4 Regeneron Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.5.5 Regeneron Recent Development
11.6 Santen
11.6.1 Santen Company Details
11.6.2 Santen Business Overview
11.6.3 Santen Retinal Disease Therapeutics Introduction
11.6.4 Santen Revenue in Retinal Disease Therapeutics Business (2016-2021)
11.6.5 Santen Recent Development

12 Analyst’s Viewpoints/Conclusions

13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

List of Tables
Table 1. Global Retinal Disease Therapeutics Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
Table 2. Key Players of Macular Degeneration
Table 3. Key Players of Diabetic Macular Edema
Table 4. Key Players of Diabetic Retinopathy
Table 5. Key Players of Retinal Vein Occlusion
Table 6. Global Retinal Disease Therapeutics Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
Table 7. Global Retinal Disease Therapeutics Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
Table 8. Global Retinal Disease Therapeutics Market Size by Regions (2016-2021) & (US$ Million)
Table 9. Global Retinal Disease Therapeutics Market Share by Regions (2016-2021)
Table 10. Global Retinal Disease Therapeutics Forecasted Market Size by Regions (2022-2027) & (US$ Million)
Table 11. Global Retinal Disease Therapeutics Market Share by Regions (2022-2027)
Table 12. Retinal Disease Therapeutics Market Trends
Table 13. Retinal Disease Therapeutics Market Drivers
Table 14. Retinal Disease Therapeutics Market Challenges
Table 15. Retinal Disease Therapeutics Market Restraints
Table 16. Global Retinal Disease Therapeutics Revenue by Players (2016-2021) & (US$ Million)
Table 17. Global Retinal Disease Therapeutics Market Share by Players (2016-2021)
Table 18. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disease Therapeutics as of 2020)
Table 19. Ranking of Global Top Retinal Disease Therapeutics Companies by Revenue (US$ Million) in 2020
Table 20. Global 5 Largest Players Market Share by Retinal Disease Therapeutics Revenue (CR5 and HHI) & (2016-2021)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Retinal Disease Therapeutics Product Solution and Service
Table 23. Date of Enter into Retinal Disease Therapeutics Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 26. Global Retinal Disease Therapeutics Revenue Market Share by Type (2016-2021)
Table 27. Global Retinal Disease Therapeutics Forecasted Market Size by Type (2022-2027) (US$ Million)
Table 28. Global Retinal Disease Therapeutics Revenue Market Share by Type (2022-2027) & (US$ Million)
Table 29. Global Retinal Disease Therapeutics Market Size Share by Application (2016-2021) & (US$ Million)
Table 30. Global Retinal Disease Therapeutics Revenue Market Share by Application (2016-2021)
Table 31. Global Retinal Disease Therapeutics Forecasted Market Size by Application (2022-2027) (US$ Million)
Table 32. Global Retinal Disease Therapeutics Revenue Market Share by Application (2022-2027) & (US$ Million)
Table 33. North America Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 34. North America Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 35. North America Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 36. North America Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 37. North America Retinal Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 38. North America Retinal Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 39. Europe Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 40. Europe Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 41. Europe Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 42. Europe Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 43. Europe Retinal Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 44. Europe Retinal Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 45. Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 46. Asia-Pacific Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 47. Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 48. Asia-Pacific Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 49. Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2016-2021) & (US$ Million)
Table 50. Asia-Pacific Retinal Disease Therapeutics Market Size by Region (2022-2027) & (US$ Million)
Table 51. Latin America Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 52. Latin America Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 53. Latin America Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 54. Latin America Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 55. Latin America Retinal Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 56. Latin America Retinal Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 57. Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2016-2021) (US$ Million)
Table 58. Middle East & Africa Retinal Disease Therapeutics Market Size by Type (2022-2027) & (US$ Million)
Table 59. Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2016-2021) (US$ Million)
Table 60. Middle East & Africa Retinal Disease Therapeutics Market Size by Application (2022-2027) & (US$ Million)
Table 61. Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2016-2021) & (US$ Million)
Table 62. Middle East & Africa Retinal Disease Therapeutics Market Size by Country (2022-2027) & (US$ Million)
Table 63. Merck Company Details
Table 64. Merck Business Overview
Table 65. Merck Retinal Disease Therapeutics Product
Table 66. Merck Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 67. Merck Recent Development
Table 68. Novartis Company Details
Table 69. Novartis Business Overview
Table 70. Novartis Retinal Disease Therapeutics Product
Table 71. Novartis Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 72. Novartis Recent Development
Table 73. Allergan Company Details
Table 74. Allergan Business Overview
Table 75. Allergan Retinal Disease Therapeutics Product
Table 76. Allergan Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 77. Allergan Recent Development
Table 78. Roche Company Details
Table 79. Roche Business Overview
Table 80. Roche Retinal Disease Therapeutics Product
Table 81. Roche Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 82. Roche Recent Development
Table 83. Regeneron Company Details
Table 84. Regeneron Business Overview
Table 85. Regeneron Retinal Disease Therapeutics Product
Table 86. Regeneron Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 87. Regeneron Recent Development
Table 88. Santen Company Details
Table 89. Santen Business Overview
Table 90. Santen Retinal Disease Therapeutics Product
Table 91. Santen Revenue in Retinal Disease Therapeutics Business (2016-2021) & (US$ Million)
Table 92. Santen Recent Development
Table 93. Research Programs/Design for This Report
Table 94. Key Data Information from Secondary Sources
Table 95. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Retinal Disease Therapeutics Market Share by Type: 2020 VS 2027
Figure 2. Macular Degeneration Features
Figure 3. Diabetic Macular Edema Features
Figure 4. Diabetic Retinopathy Features
Figure 5. Retinal Vein Occlusion Features
Figure 6. Global Retinal Disease Therapeutics Market Share by Application: 2020 VS 2027
Figure 7. Hospital Pharmacy Case Studies
Figure 8. Retail Pharmacy Case Studies
Figure 9. Others Case Studies
Figure 10. Retinal Disease Therapeutics Report Years Considered
Figure 11. Global Retinal Disease Therapeutics Market Size (US$ Million), Year-over-Year: 2016-2027
Figure 12. Global Retinal Disease Therapeutics Market Size (US$ Million), 2016 VS 2021 VS 2027
Figure 13. Global Retinal Disease Therapeutics Market Share by Regions: 2020 VS 2027
Figure 14. Global Retinal Disease Therapeutics Market Share by Regions (2022-2027)
Figure 15. Global Retinal Disease Therapeutics Market Share by Players in 2020
Figure 16. Global Top Retinal Disease Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Retinal Disease Therapeutics as of 2020
Figure 17. The Top 10 and 5 Players Market Share by Retinal Disease Therapeutics Revenue in 2020
Figure 18. Global Retinal Disease Therapeutics Revenue Market Share by Type (2016-2021)
Figure 19. Global Retinal Disease Therapeutics Revenue Market Share by Type (2022-2027)
Figure 20. North America Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 21. North America Retinal Disease Therapeutics Market Share by Type (2016-2027)
Figure 22. North America Retinal Disease Therapeutics Market Share by Application (2016-2027)
Figure 23. North America Retinal Disease Therapeutics Market Share by Country (2016-2027)
Figure 24. United States Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 25. Canada Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 26. Europe Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 27. Europe Retinal Disease Therapeutics Market Share by Type (2016-2027)
Figure 28. Europe Retinal Disease Therapeutics Market Share by Application (2016-2027)
Figure 29. Europe Retinal Disease Therapeutics Market Share by Country (2016-2027)
Figure 30. Germany Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 31. France Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 32. U.K. Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 33. Italy Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 34. Russia Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 35. Nordic Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 36. Asia-Pacific Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 37. Asia-Pacific Retinal Disease Therapeutics Market Share by Type (2016-2027)
Figure 38. Asia-Pacific Retinal Disease Therapeutics Market Share by Application (2016-2027)
Figure 39. Asia-Pacific Retinal Disease Therapeutics Market Share by Region (2016-2027)
Figure 40. China Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 41. Japan Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 42. South Korea Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 43. Southeast Asia Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 44. India Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 45. Australia Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 46. Latin America Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 47. Latin America Retinal Disease Therapeutics Market Share by Type (2016-2027)
Figure 48. Latin America Retinal Disease Therapeutics Market Share by Application (2016-2027)
Figure 49. Latin America Retinal Disease Therapeutics Market Share by Country (2016-2027)
Figure 50. Mexico Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 51. Brazil Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 52. Middle East & Africa Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 53. Middle East & Africa Retinal Disease Therapeutics Market Share by Type (2016-2027)
Figure 54. Middle East & Africa Retinal Disease Therapeutics Market Share by Application (2016-2027)
Figure 55. Middle East & Africa Retinal Disease Therapeutics Market Share by Country (2016-2027)
Figure 56. Turkey Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 57. Saudi Arabia Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 58. UAE Retinal Disease Therapeutics Market Size YoY Growth (2016-2027) & (US$ Million)
Figure 59. Merck Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021)
Figure 60. Novartis Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021)
Figure 61. Allergan Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021)
Figure 62. Roche Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021)
Figure 63. Regeneron Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021)
Figure 64. Santen Revenue Growth Rate in Retinal Disease Therapeutics Business (2016-2021)
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed

---